
TY  - JOUR
TI  - ACVIM ABSTRACTS
JO  - Journal of Veterinary Internal Medicine
VL  - 10
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.1996.tb02047.x
DO  - doi:10.1111/j.1939-1676.1996.tb02047.x
SP  - 143
EP  - 195
PY  - 1996
ER  - 

TY  - JOUR
TI  - ASBMR 31st Annual Meeting MO0001–MO0445
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 24
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650241305
DO  - doi:10.1002/jbmr.5650241305
SP  - S370
EP  - S496
PY  - 2009
ER  - 

TY  - JOUR
TI  - 2014 ACVIM Forum Research Abstracts Program
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 28
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.12361
DO  - doi:10.1111/jvim.12361
SP  - 976
EP  - 1134
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstract Presentations from the AABB Annual Meeting San Diego, CA ctober 7-10, 2017
JO  - Transfusion
JA  - Transfusion
VL  - 57
IS  - S3
SN  - 0041-1132
UR  - https://doi.org/10.1111/trf.14286
DO  - doi:10.1111/trf.14286
SP  - 3A
EP  - 264A
PY  - 2017
ER  - 

TY  - JOUR
AU  - Jones, Allan
AU  - Friedrich, Kilian
AU  - Rohm, Maria
AU  - Schäfer, Michaela
AU  - Algire, Carolyn
AU  - Kulozik, Philipp
AU  - Seibert, Oksana
AU  - Müller-Decker, Karin
AU  - Sijmonsma, Tjeerd
AU  - Strzoda, Daniela
AU  - Sticht, Carsten
AU  - Gretz, Norbert
AU  - Dallinga-Thie, Geesje M.
AU  - Leuchs, Barbara
AU  - Kögl, Manfred
AU  - Stremmel, Wolfgang
AU  - Diaz, Mauricio Berriel
AU  - Herzig, Stephan
TI  - TSC22D4 is a molecular output of hepatic wasting metabolism
JO  - EMBO Molecular Medicine
JA  - EMBO Mol Med
VL  - 5
IS  - 2
SN  - 1757-4676
UR  - https://doi.org/10.1002/emmm.201201869
DO  - doi:10.1002/emmm.201201869
SP  - 294
EP  - 308
KW  - cancer cachexia
KW  - lipid metabolism
KW  - liver
KW  - transcription
KW  - TSC22D4
PY  - 2013
AB  - Abstract In mammals, proper storage and distribution of lipids in and between tissues is essential for the maintenance of energy homeostasis. Here, we show that tumour growth triggers hepatic metabolic dysfunction as part of the cancer cachectic phenotype, particularly by reduced hepatic very-low-density-lipoprotein (VLDL) secretion and hypobetalipoproteinemia. As a molecular cachexia output pathway, hepatic levels of the transcription factor transforming growth factor beta 1-stimulated clone (TSC) 22 D4 were increased in cancer cachexia. Mimicking high cachectic levels of TSC22D4 in healthy livers led to the inhibition of hepatic VLDL release and lipogenic genes, and diminished systemic VLDL levels under both normal and high fat dietary conditions. Liver-specific ablation of TSC22D4 triggered hypertriglyceridemia through the induction of hepatic VLDL secretion. Furthermore, hepatic TSC22D4 expression levels were correlated with the degree of body weight loss and VLDL hypo-secretion in cancer cachexia, and TSC22D4 deficiency rescued tumour cell-induced metabolic dysfunction in hepatocytes. Therefore, hepatic TSC22D4 activity may represent a molecular rationale for peripheral energy deprivation in subjects with metabolic wasting diseases, including cancer cachexia.
ER  - 

TY  - JOUR
TI  - ASGBI abstracts 2007 Oral presentations
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 94
IS  - S2
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.5848
DO  - doi:10.1002/bjs.5848
SP  - 1
EP  - 78
PY  - 2007
AB  - Abstract The Annual Scientific Meeting of the Association of Surgeons of Great Britain and Ireland takes place this year at Manchester Central (18th - 20th April 2007), under the presidency of Professor Brian J Rowlands. To view all abstracts of oral presentations from this meeting, please click the pdf link on this page.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - HPB
VL  - 12
IS  - s1
SN  - 1365-182X
UR  - https://doi.org/10.1111/j.1477-2574.2010.00165.x
DO  - doi:10.1111/j.1477-2574.2010.00165.x
SP  - 1
EP  - 468
PY  - 2010
ER  - 

TY  - JOUR
TI  - POSTER PRESENTATION: BILIARY
JO  - HPB
VL  - 14
IS  - s2
SN  - 1365-182X
UR  - https://doi.org/10.1111/j.1477-2574.2012.00512.x
DO  - doi:10.1111/j.1477-2574.2012.00512.x
SP  - 288
EP  - 699
PY  - 2012
ER  - 

TY  - JOUR
TI  - Summary of the scientific programme of the European and national sessions
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 81
IS  - S1
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.1800811202
DO  - doi:10.1002/bjs.1800811202
SP  - 2
EP  - 137
PY  - 1994
ER  - 

TY  - JOUR
TI  - The abstracts of Eurosurgery 95
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 82
IS  - S1
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.1800821302
DO  - doi:10.1002/bjs.1800821302
SP  - 1
EP  - 144
PY  - 1995
ER  - 

TY  - JOUR
TI  - Aspen 6th Clinical Congress Proceedings
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 5
IS  - 6
SN  - 0148-6071
UR  - https://doi.org/10.1177/014860718100500619
DO  - doi:10.1177/014860718100500619
SP  - 552
EP  - 582
PY  - 1981
ER  - 

TY  - JOUR
TI  - Keyword index
JO  - European Journal of Clinical Investigation
VL  - 35
IS  - 12
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2005.01582.x
DO  - doi:10.1111/j.1365-2362.2005.01582.x
SP  - 791
EP  - 793
PY  - 2005
ER  - 

TY  - JOUR
AU  - Hernández-Neuta, I.
AU  - Neumann, F.
AU  - Brightmeyer, J.
AU  - Ba Tis, T.
AU  - Madaboosi, N.
AU  - Wei, Q.
AU  - Ozcan, A.
AU  - Nilsson, M.
TI  - Smartphone-based clinical diagnostics: towards democratization of evidence-based health care
JO  - Journal of Internal Medicine
JA  - J Intern Med
VL  - 285
IS  - 1
SN  - 0954-6820
UR  - https://doi.org/10.1111/joim.12820
DO  - doi:10.1111/joim.12820
SP  - 19
EP  - 39
KW  - Biosensors
KW  - Diagnostics
KW  - Digital pathology
KW  - Lab-on-a-chip
KW  - Smartphones
PY  - 2019
AB  - Abstract Recent advancements in bioanalytical techniques have led to the development of novel and robust diagnostic approaches that hold promise for providing optimal patient treatment, guiding prevention programs and widening the scope of personalized medicine. However, these advanced diagnostic techniques are still complex, expensive and limited to centralized healthcare facilities or research laboratories. This significantly hinders the use of evidence-based diagnostics for resource-limited settings and the primary care, thus creating a gap between healthcare providers and patients, leaving these populations without access to precision and quality medicine. Smartphone-based imaging and sensing platforms are emerging as promising alternatives for bridging this gap and decentralizing diagnostic tests offering practical features such as portability, cost-effectiveness and connectivity. Moreover, towards simplifying and automating bioanalytical techniques, biosensors and lab-on-a-chip technologies have become essential to interface and integrate these assays, bringing together the high precision and sensitivity of diagnostic techniques with the connectivity and computational power of smartphones. Here, we provide an overview of the emerging field of clinical smartphone diagnostics and its contributing technologies, as well as their wide range of areas of application, which span from haematology to digital pathology and rapid infectious disease diagnostics.
ER  - 

TY  - JOUR
TI  - Current literature
JO  - Journal of Human Nutrition and Dietetics
VL  - 1
IS  - 4
SN  - 0952-3871
UR  - https://doi.org/10.1111/j.1365-277X.1988.tb00200.x
DO  - doi:10.1111/j.1365-277X.1988.tb00200.x
SP  - 303
EP  - 308
PY  - 1988
ER  - 

TY  - JOUR
TI  - Surgical Research Society abstracts
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 69
IS  - 11
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.1800691116
DO  - doi:10.1002/bjs.1800691116
SP  - 676
EP  - 689
PY  - 1982
ER  - 

TY  - JOUR
TI  - European Tissue Repair Society: Joint Meeting with the Tissue Viability Unit of Malta
JO  - Wound Repair and Regeneration
VL  - 16
IS  - 6
SN  - 1067-1927
UR  - https://doi.org/10.1111/j.1524-475X.2008.00424.x
DO  - doi:10.1111/j.1524-475X.2008.00424.x
SP  - A66
EP  - A82
PY  - 2008
ER  - 

TY  - JOUR
TI  - PANCREAS
JO  - Journal of Gastroenterology and Hepatology
VL  - 21
IS  - s6
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2006.04803.x
DO  - doi:10.1111/j.1440-1746.2006.04803.x
SP  - A426
EP  - A434
PY  - 2006
ER  - 

TY  - JOUR
AU  - Aronica, Eleonora
AU  - Bauer, Sebastian
AU  - Bozzi, Yuri
AU  - Caleo, Matteo
AU  - Dingledine, Raymond
AU  - Gorter, Jan A.
AU  - Henshall, David C.
AU  - Kaufer, Daniela
AU  - Koh, Sookyong
AU  - Löscher, Wolfgang
AU  - Louboutin, Jean-Pierre
AU  - Mishto, Michele
AU  - Norwood, Braxton A.
AU  - Palma, Eleonora
AU  - Poulter, Michael O.
AU  - Terrone, Gaetano
AU  - Vezzani, Annamaria
AU  - Kaminski, Rafal M.
TI  - Neuroinflammatory targets and treatments for epilepsy validated in experimental models
JO  - Epilepsia
JA  - Epilepsia
VL  - 58
IS  - S3
SN  - 0013-9580
UR  - https://doi.org/10.1111/epi.13783
DO  - doi:10.1111/epi.13783
SP  - 27
EP  - 38
KW  - Inflammation
KW  - Immune response
KW  - Drug development
KW  - Anti-ictogenesis
KW  - Antiepileptogenesis
KW  - Disease modification
KW  - Epilepsy
PY  - 2017
AB  - Summary A large body of evidence that has accumulated over the past decade strongly supports the role of inflammation in the pathophysiology of human epilepsy. Specific inflammatory molecules and pathways have been identified that influence various pathologic outcomes in different experimental models of epilepsy. Most importantly, the same inflammatory pathways have also been found in surgically resected brain tissue from patients with treatment-resistant epilepsy. New antiseizure therapies may be derived from these novel potential targets. An essential and crucial question is whether targeting these molecules and pathways may result in anti-ictogenesis, antiepileptogenesis, and/or disease-modification effects. Therefore, preclinical testing in models mimicking relevant aspects of epileptogenesis is needed to guide integrated experimental and clinical trial designs. We discuss the most recent preclinical proof-of-concept studies validating a number of therapeutic approaches against inflammatory mechanisms in animal models that could represent novel avenues for drug development in epilepsy. Finally, we suggest future directions to accelerate preclinical to clinical translation of these recent discoveries.
ER  - 

C7  - pp. 433-442
TI  - Index
SN  - 9781444335552
UR  - https://doi.org/10.1002/9781444398854.index
DO  - doi:10.1002/9781444398854.index
SP  - 433-442
PY  - 2017
ER  - 

TY  - JOUR
TI  - Issue information - TOC
JO  - ANZ Journal of Surgery
JA  - ANZ Journal of Surgery
VL  - 88
IS  - 7-8
SN  - 9781444335552
UR  - https://doi.org/10.1111/ans.14786
DO  - doi:10.1111/ans.14786
SP  - 658
EP  - 661
PY  - 2018
ER  - 
